Seeking Alpha

Vertex Pharmaceuticals (VRTX -12.3%) slides on weaker-than-expected Q3 results and a downgrade...

Vertex Pharmaceuticals (VRTX -12.3%) slides on weaker-than-expected Q3 results and a downgrade to Neutral by Goldman. Citing the weak results and the recent NACFC conference, Goldman says it's formed a more cautious outlook on the company's key pipeline program, and sees a limited number of upside catalysts heading into 2013.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)